Economic Burden Associated With Extended-Release vs Immediate-Release Drug Formulations Among Medicare Part D and Medicaid Beneficiaries

IMPORTANCE: The United States spends more money on medications than any other country. Most extended-release drugs have not consistently shown therapeutic or adherence superiority, and switching these medications to less expensive, generic, immediate-release formulations may offer an opportunity to...

Descripción completa

Detalles Bibliográficos
Autores principales: Sumarsono, Andrew, Sumarsono, Nathan, Das, Sandeep R., Vaduganathan, Muthiah, Agrawal, Deepak, Pandey, Ambarish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049080/
https://www.ncbi.nlm.nih.gov/pubmed/32108893
http://dx.doi.org/10.1001/jamanetworkopen.2020.0181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049080/
https://www.ncbi.nlm.nih.gov/pubmed/32108893
http://dx.doi.org/10.1001/jamanetworkopen.2020.0181

Ejemplares similares